Cogent Biosciences (COGT) Prepaid Assets (2017 - 2026)

Cogent Biosciences (COGT) has reported Prepaid Assets for 10 consecutive years, with $11.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 58.18% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (up 58.18% YoY), while the FY2025 annual figure was $9.6 million, up 2.08% from the prior year.
• Prepaid Assets rose to $11.4 million in Q1 2026 per COGT's latest filing, from $9.6 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $11.4 million in Q1 2026 and bottomed at $3.7 million in Q1 2022.
• Historically, Prepaid Assets has averaged $6.5 million across 5 years, with a median of $6.2 million in 2024.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 177.14% — and 2024, when it declined 13.06%.
• Cogent Biosciences' Prepaid Assets stood at $4.4 million in 2022, then increased by 14.11% to $5.1 million in 2023, then jumped by 85.64% to $9.4 million in 2024, then grew by 2.08% to $9.6 million in 2025, then climbed by 19.13% to $11.4 million in 2026.
• Business Quant data shows COGT's Prepaid Assets at $11.4 million in Q1 2026, $9.6 million in Q4 2025, and $6.4 million in Q3 2025.